Tilray Brands (TLRY) Profit After Tax (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Profit After Tax (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn |
| 10 | Tilray Brands | 456.90 Mn | 396.70 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 23.37% |
| Nov 30, 2025 | -3,046.79% |
| Aug 31, 2025 | 100.10% |
| May 31, 2025 | -59.98% |
| Feb 28, 2025 | -737.68% |
| Nov 30, 2024 | -209.07% |
| Aug 31, 2024 | -148.83% |
| May 31, 2024 | 88.33% |
| Feb 29, 2024 | -156.18% |
| Nov 30, 2023 | 22.17% |
| Aug 31, 2023 | 54.80% |
| May 31, 2023 | -19,516.17% |
| Feb 28, 2023 | 100.58% |
| Nov 30, 2022 | 21.57% |
| Aug 31, 2022 | 80.35% |
| May 31, 2022 | -1,660.32% |
| Feb 28, 2022 | 200.73% |
| Nov 30, 2021 | 68.48% |
| Aug 31, 2021 | -388.16% |
| May 31, 2021 | 117.26% |